5SX5
Crystal Structure of panitumumab in complex with epidermal growth factor receptor domain 3 mutant S468R.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ALS BEAMLINE 5.0.2 |
| Synchrotron site | ALS |
| Beamline | 5.0.2 |
| Temperature [K] | 80 |
| Detector technology | CCD |
| Collection date | 2014-11-07 |
| Detector | ADSC QUANTUM 315 |
| Wavelength(s) | 1.0 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 65.073, 113.106, 231.403 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 29.979 - 2.500 |
| R-factor | 0.2269 |
| Rwork | 0.226 |
| R-free | 0.24980 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 1yy9 |
| RMSD bond length | 0.002 |
| RMSD bond angle | 0.495 |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHASER |
| Refinement software | PHENIX (dev_2356) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 30.000 | 30.000 | 2.590 |
| High resolution limit [Å] | 2.500 | 5.380 | 2.500 |
| Rmerge | 0.046 | 0.022 | 0.453 |
| Rmeas | 0.053 | ||
| Rpim | 0.026 | ||
| Total number of observations | 239127 | ||
| Number of reflections | 58643 | ||
| <I/σ(I)> | 14.2 | ||
| Completeness [%] | 97.6 | 99.6 | 92 |
| Redundancy | 4.1 | 4.2 | 3.8 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 293 | 2.0 M AmSO4, 100 mM MES 6.5 and 5% peg 400 |






